Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NASDAQ pre market Top 10, quote delayed
https://ih.advfn.com/markets/nasdaq/premarket
$MEGL 500 shares of mine :]
AVGR $1.61 ***50ma break 7 mill o/s breakout ready check the chart !
The investment tax credit (ITC), used by the solar industry, will cost federal taxpayers about $60 billion.
Senate passes bill! > Huge catalyst for PEGY in upcoming sessions. Now will most likely pass House this week.
,,,$PEGY,,,,,,,CLEAN ENERGY BILL PASSES……GET IN EARLY
https://www.forbes.com/sites/robertbryce/2022/08/05/big-wind-and-big-solar-will-collect-113-billion-in-tax-credits-this-decade-manchin-schumer-assures--billions-more/?sh=26edb35e29d0
Forza X1, Inc. (FRZA)
Forza X1 will go public soon. The estimated IPO date is August 11, 2022.
Stock Price: $5.00
Confirmed IPO price
Overview
Financials
Statistics
Dividends
Profile
Company Description
Forza X1 aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal.
Our mission is to inspire the adoption of sustainable recreational boating by mass producing stylish electric sport boats. We are focused on the creation and implementation of marine electric vehicle technology to control and power our electric boats utilizing our proprietary outboard electric motor.
We intend to offer our EV products and services through a vertically integrated and premium direct-to-consumer system. We intend to create a superior customer experience that spans the entire life of our products through an online system that is being designed to be comprehensive, seamless, and touchless.
What good is having wealth on a planet that becomes unhabitable?
Due to climate change, Nevada says goodbye to grass
CBSNews - 9h ago
371 Comments
|
487
Share
In Las Vegas, Nevada, it's come to this: climate change has helped make water ever more scarce, so under a new Nevada law, the grass has got to go. "When we look at outdoor water use in Southern Nevada, landscaping far and away is the largest water user, and of that, it's grass," said Bronson Mack of the Las Vegas Water Authority.
When and how much of it goes down the drain?
Pause
Current Time 1:22
/
Duration 8:54
LQ
CaptionsFullscreen
Experts call for more public urgency on climate change
Unmute
0
View on Watch
The city's already pulled up about four million square feet of grass on public property so far this year, because thirsty green parkways are something they just can't afford anymore. "The grass that you see behind me is not long for this world," Mack told correspondent Tracy Smith. "In fact, within the next couple of months to a year, this grass will be completely eliminated, and it'll be replaced with drip-irrigated trees and plants."
$TDUP $GENI $FUBO
I'm getting a chuckle from the JCSE corporate profile
JE Cleantech Holdings Ltd NASDAQ: JCSE
JCSE
GoSymbol lookup
Based in SingaporeCompany profile
JE Cleantech Holdings Limited is engaged in the sale of cleaning systems and other equipment and the provision of centralized dishwashing and ancillary services. It manufactures a range of cleaning systems, including aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment. It also provides centralized dishwashing services for the food and beverage industry, mainly for food and beverage establishments in Singapore such as food courts, hawker centers, restaurants, cookhouses, eldercare homes, and an inflight catering service provider. It also provides general cleaning services mainly for food courts in Singapore. It provides centralized dishwashing services at its Hygieia Facility in Singapore. It also provides leasing services of dishwashing equipment to its customers. The terms of the leases are typically for a period of one to two years (s) and renew automatically, and its customers are charged a fixed monthly fee for such leasing services.
Meanwhile, this from Wikipedia. My takeaway is these folks got lots of money.
Singapore (/'s??(g)?p??r/ (listen)), officially the Republic of Singapore, is a sovereign island country and city-state in maritime Southeast Asia. It lies about one degree of latitude (137 kilometres or 85 miles) north of the equator, off the southern tip of the Malay Peninsula, bordering the Strait of Malacca to the west, the Singapore Strait to the south, the South China Sea to the east, and the Straits of Johor to the north. The country's territory is composed of one main island, 63 satellite islands and islets, and one outlying islet, the combined area of which has increased by 25% since the country's independence as a result of extensive land reclamation projects. It has the third highest population density in the world. With a multicultural population and recognising the need to respect cultural identities of the major ethnic groups within the nation, Singapore has four official languages; English, Malay, Mandarin, and Tamil. English is the lingua franca and numerous public services are available only in English. Multiracialism is enshrined in the constitution and continues to shape national policies in education, housing, and politics.
Singapore has the world's highest percentage of millionaires, with one out of every six households having at least one million US dollars in disposable wealth. This excludes property, businesses, and luxury goods, which if included would increase the number of millionaires, especially as property in Singapore is among the world's most expensive.[277] In 2016, Singapore was rated the world's most expensive city for the third consecutive year by the Economist Intelligence Unit,[278][279] and this remained true in 2018.[280] The government provides numerous assistance programmes to the homeless and needy through the Ministry of Social and Family Development, so acute poverty is rare. Some of the programmes include providing between S$400 and S$1000 of financial assistance per month to needy households, providing free medical care at government hospitals, and paying for children's tuition.[281][282][283] Other benefits include compensation for gym fees to encourage citizens to exercise,[284] up to S$166,000 as a baby bonus for each citizen,[285] heavily subsidised healthcare, financial aid for the disabled, the provision of reduced-cost laptops for poor students,[286] rebates for costs such as public transport[287] and utility bills, and more.[288][289] As of 2018 Singapore's ranking in the Human Development Index is 9th in the world, with an HDI value of 0.935.
The median age of Singaporean residents was 40.5 in 2017,[375] and the total fertility rate is estimated to be 0.80 children per woman in 2014, the lowest in the world and well below the 2.1 needed to replace the population.[376] The government has attempted to increase fertility with limited success, as well as adjusting immigration policy to maintain its working-age population.[377][378]
91% of resident households (i.e. households headed by a Singapore citizen or permanent resident) own the homes they live in, and the average household size is 3.43 persons (which include dependants who are neither citizens nor permanent residents).[379][380] However, due to scarcity of land, 78.7% of resident households live in subsidised, high-rise, public housing apartments developed by the Housing and Development Board (HDB). Also, 75.9% of resident households live in properties that are equal to, or larger than, a four-room (i.e. three bedrooms plus one living room) HDB flat or in private housing.[381][382] Live-in foreign domestic workers are quite common in Singapore, with about 224,500 foreign domestic workers there, as of December 2013.[383]
Singapore has a generally efficient healthcare system, even though health expenditures are relatively low for developed countries.[446] The World Health Organisation ranks Singapore's healthcare system as 6th overall in the world in its World Health Report.[447] Singapore has had the lowest infant mortality rates in the world for the past two decades.[448] In 2019, Singaporeans had the longest life expectancy of any country at 84.8 years. Women can expect to live an average of 87.6 years with 75.8 years in good health. The averages are lower for men.[449] Singapore is ranked 1st on the Global Food Security Index.[450]
$JCSE $1.96 watch this one this week -- MUST break $2.36 -- support MUST Hold 1.80
https://schrts.co/WpMVBEPP
This Google Fiber is a hell of lot faster than Spectrum.
What's in store tomorrow at 4AM when the Webull platform opens for orders?
Stay tuned...
AdChoices
ABC News
ABC News
Follow
View Profile
Senate Democrats pass climate, tax and health care bill after marathon voting session
48m ago
1k Comments
|
2k
Share
The Senate on Sunday passed the Inflation Reduction Act (IRA) along party lines, 51-50, handing Democrats a crucial legislative win as the midterm cycle ramps up -- despite GOP objections at the billions in spending and drug pricing reforms.
climate change in U.S. history. It lowers prescription drug costs for
Pause
Current Time 0:15
/
Duration 6:20
LQ
CaptionsFullscreen
'It may take a year or more' for budget bill to reduce inflation: Sen. Coons
Unmute
0
View on Watch
The sprawling climate, tax and health care legislation is now set up for quick passage in the Democratic-controlled House, with timing still to be announced, before President Joe Biden signs it into law.
The Killer Bank CD Alternative - Beat Your Bank's Pathetic Rate
Ad
www.annuityresources.com
The Killer Bank CD Alternative - Beat Your Bank's Pathetic Rate
Included in the bill, supporters are quick to highlight, are measures to foster job creation, raise taxes on large corporations and the wealthy, allow Medicare to negotiate down some prescription drug costs, expand the Affordable Care Act health care program and invest in combating climate change by implementing tax credits for clean energy initiatives, among other things.
Vice President Kamala Harris cast the tie-breaking vote in the Senate with all Democrats in support of the legislation and all Republicans opposed. The proposal was passed via the budget reconciliation process, which requires a simple majority rather than the 60 votes typically needed to overcome a filibuster.
The rules of reconciliation, however, limit what can and cannot be passed with 51 votes -- strictures that narrowed the legislation's scope even in the final days before the vote.
MORE: What's in the Senate Democrats' landmark 'Inflation Reduction Act'?
The legislation's tax provisions, prescription drug-pricing reform, as well as boosted IRS tax enforcement measures, are anticipated to raise an estimated revenue of $739 billion -- $300 billion of which Democrats say would go toward reducing the deficit.
The plan would reduce federal budget deficits by $102 billion over 10 years, according to the nonpartisan Congressional Budget Office. Despite the bill's name, however, the CBO found that it would have a minimal affect on high inflation in the short-term -- something Democrats have conceded when pressed.
The bill passed the Senate after a punishing, approximately 16-hour "vote-a-rama," in which any senator could introduce an amendment to the bill as part of the reconciliation process.
The amendment process fueled painful votes for each party.
Vulnerable Democratic incumbents up for reelection this year had to dance around a vote on the Biden administration's decision to scrap Title 42, a Trump-era order using coronavirus concerns to prevent migrants from entering the country while seeking asylum. Republicans, meanwhile, mostly voted against a Democratic amendment that would have capped out-of-pocket insulin costs at $35 a month for people with private health insurance.
Senator Patrick Leahy is wheeled to an elevator from the Senate floor during amendment votes, also called the "vote-a-rama", on the Inflation Reduct Act 2022, at the U.S. Capitol building in Washington, Aug. 7, 2022.
© Ken Cedeno/Reuters
Senator Patrick Leahy is wheeled to an elevator from the Senate floor during amendment votes, also called the "vote-a-rama", on the Inflation Reduct Act 2022, at the U.S. Capitol building in Washington, Aug. 7, 2022.
The IRA passage marks the culmination of grueling negotiations between Senate Majority Leader Chuck Schumer, D-N.Y., and Sen. Joe Manchin, D-W.Va., who had been a consistent obstacle to cobbling together a Democrats-only social spending bill via reconciliation.
The pathway for a successful vote was cemented late last week when Sen. Kyrsten Sinema, D-Ariz., another key centrist, signed on after winning some tweaks to the bill.
Among the changes Sinema won were the eliminations of tax provisions targeting wealthy hedge-fund managers and private equity executives. The Senate rules official, the parliamentarian, also scrapped a provision intended to reprimand drug companies that raise the prices of some prescription drugs faster than inflation for patients with private insurance.
Still, the bill's passage marks a major step toward President Biden's campaign promises to tackle climate change, reform drug pricing and other issues; and it gives Democrats a new legislative win to run on heading into the November midterms, in an environment where many voters have soured on Biden's handling of the economy and historic inflation.
"Today, Senate Democrats sided with American families over special interests, voting to lower the cost of prescription drugs, health insurance, and everyday energy costs and reduce the deficit, while making the wealthiest corporations finally pay their fair share. I ran for President promising to make government work for working families again, and that is what this bill does -- period," Biden said in a statement
The IRA also extends a streak of achievements for Biden and congressional Democrats, including passage of a bipartisan anti-gun violence bill and legislation to boost the domestic semiconductor industry.
MORE: Democrats advance the Inflation Reduction Act, setting up Senate 'vote-a-rama'
"This bill is going to change America for decades," Schumer crowed after final passage.
Republicans have already forecasted that they'll paint Democrats as uncaring about Americans' financial burdens at a time of rapid price hikes while passing billions of dollars in new spending.
"This idea that this massive tax increase will just somehow be absorbed by corporate America when they will pass those costs along to consumers, and it will make inflation worse," Senate Minority Whip John Cornyn, R-Texas, said last week.
Sen. Mike Rounds, R-S.D., said on ABC's "This Week" on Sunday that the IRA would be not a boon to the country but a "boondoggle."
"What they're really trying to do is to take dollars in and then redistribute it back out to the places that they think it should be done … This is not the time to be experimenting in that area," he said.
He also contended that Medicare's drug negotiating power wouldn't pay off: "This is not healthy, it's not good and it will cause problems in the marketplace."
Accelerate Diagnostics Inc NASDAQ: AXDX
AXDX
GoSymbol lookup
Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.
ThredUp Inc NASDAQ: TDUP
TDUP
GoSymbol lookup
Consumer Discretionary : Internet & Direct Marketing Retail | Small Cap BlendCompany profile
ThredUp Inc. is an online resale platform for women’s and kids’ apparel, shoes and accessories. The Company’s marketplace enables buyers to browse and purchase resale items primarily women’s and kids’ apparel, shoes and accessories across a range of price points. Its custom-built operating platform consists of distributed processing infrastructure, software and systems and data science expertise. The Company’s subsidiaries include ThredUp Intermediary Holdings LLC, Knitwit GC LLC, ThredUp CF LLC, thredUP Circular Fashion Fund Inc. and Remix Global EAD.
23andMe Holding Co. NASDAQ: ME
ME
GoSymbol lookup
Health Care : Life Sciences Tools & Services | Small Cap BlendCompany profile
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. Its telehealth platform provides patients with access to medical consultation and treatment. Through its research services, it uses its database of genetic and phenotypic information to identify targets for drug development. The Therapeutics segment focuses on the use of genetic insights from its database of genetic and phenotypic information to develop therapies to improve patients lives.
You can't win if you don't bet
Genius Sports Ltd NYSE: GENI
GENI
GoSymbol lookup
Communication Services : Interactive Media & Services | Small Cap Growth | Based in United KingdomCompany profile
Genius Sports Limited is a provider of technology-led products and services to the sports, sports wagering and sports media industries. Its offerings include Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. It builds and supplies technology and services that allow sports leagues to collect, analyze and monetize their data with added tools to deepen fan engagement. It also offers sports leagues with bespoke monitoring technology and education services to help protect their competitions and athletes from the threats of match fixing and betting-related corruption. It offers official data, outsourced bookmaking, trading/risk management services and live audio-visual game content that is derived from its streaming partnerships with sports leagues. It builds and supplies technology, services and data that enable sportsbooks, sports organizations, and other brands to target, acquire and retain sports fans as their customers.
China has resumed growing but at a slower pace.
https://www.barchart.com/story/news/9537067/china-july-exports-rise-with-trade-surplus-at-record-high
Peleton (PTON) going higher. You can't be serious. From the Barchart website:
https://www.barchart.com/story/news/9537490/peloton-s-unusual-call-volume-implies-the-stock-will-move-higher
From the Barchart Medical Information Systems sector
Senseonics Holdings Inc NYSE American: SENS
SENS
GoSymbol lookup
Health Care : Health Care Equipment & Supplies | Small Cap ValueCompany profile
Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually to measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. It is also developing its Freedom product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor, which can be utilized with a smart transmitter to get continuous glucose readings and alerts, or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose reading without a smart transmitter.
From the Barchart Medical Information Systems sector
Tivic Health Systems Inc NASDAQ: TIVC
TIVC
GoSymbol lookup
Company profile
Tivic Health Systems Inc. (Tivic Health) is a consumer health technology company. The Company is focused on bioelectronic medicine. Tivic Health's product is a non-invasive trigeminal nerve stimulation device sold as ClearUP Sinus Relief (ClearUP) is a handheld device uses ultra-low current electrical waves to relieve symptoms of sinus and nasal inflammation. It has brought bioelectronic medicine to the home treatment market for nasal allergies, sinus infections, chronic sinusitis, cold and flu. The Company is developing second-generation version of ClearUP, ClearUP Gen 2 for market. Its two ongoing product candidates include npdPP, an at home-use device for treating postoperative pain after sinus surgery, and npdMI, an at home-use device for treating migraine headaches. Tivic Health sells its products direct-to-consumer through its own Websites, Amazon.com and Walmart.com and also sells to United States online retailers such as BestBuy.com and FSAStore.com.
From the Barchart Medical Information Systems sector
Movano Inc NASDAQ: MOVE
MOVE
GoSymbol lookup
Information Technology : Technology Hardware, Storage & Peripherals | Company profile
Movano Inc. is focused on developing a platform to deliver purpose-driven healthcare solutions at the intersection of MedTech and consumer devices. The Company’s platform uses Radio Frequency (RF) technology, which enables the creation of scalable sensors that are small enough to fit into wearable devices and other small form factors. The Company’s platform is the foundation for its development of its product, Movano Ring. Its Movano Ring measures heart rate, heart rate variability (HRV), sleep, respiration, temperature, blood oxygen saturation (SpO2), steps, calories and incorporates women-centric features and design. The smart ring and its accompanying application seek to combine health metrics with personalized intelligent feedback and is designed for women of all ages. Its device insights help users make manageable lifestyle changes and take a more proactive approach to their health that could help mitigate the risks associated with chronic disease.
From the Barchart Medical Information Systems sector
Hims & Hers Health Inc NYSE: HIMS
HIMS
GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap ValueCompany profile
Hims & Hers Health, Inc., formerly Oaktree Acquisition Corp., is a telehealth platform that connects consumers to licensed healthcare professionals. The Company has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The Company has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. It offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The Company's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.
From the Barchart Medical Information Systems sector
Streamline Health Solutions Inc NASDAQ: STRM
STRM
GoSymbol lookup
Health Care : Health Care Technology | Small Cap BlendCompany profile
Streamline Health Solutions, Inc. is a provider of health information technology solutions and associated services. The Company offers computer software-based solutions and auditing services, which capture, aggregate, and translate structured and unstructured data to deliver organized, easily accessible predictive insights to its customers. It offers solutions and services to assist its customers in revenue cycle management including its two flagship technologies eValuator and Avelead Rev ID. eValuator provides automated coding analysis prior to billing. Avelead Rev ID offers reconciliation of clinical activity to patient billing records prior to billing. In addition, the Company offers an array of professional services, including system implementation and coding audit solutions and other software solutions, such as Coding and Clinical Documentation Improvement (CDI), Avelead Compare and Financial Management. The Company operates throughout the United States and Canada.
Butterfly Networks (BFLY) belongs to a Barchart sector called Medical Information Systems. Notice the chart at the top of the webpage. The sector bottomed in mid-June and is almost to where it was in April.
https://www.barchart.com/stocks/quotes/BFLY/competitors?quoteSectors=-MEIS&viewName=main&orderBy=weightedAlpha&orderDir=desc
They can fly, but they can no longer hide. From my Morning Brew email newsletter:
OK, the Millennial installed the Google Fiber Saturday evening, replacing the clunky Spectrum hardware with a little white round cylinder about 3 inches high and 6 inches in diameter, similar to Amazon's Alexa device.
Looks like Cathie Wood scored for a change. Her latest update:
Butterfly Network (BFLY)
Forgot, dammit. Still waking up. According to TD Ameritrade the short interest in FUBO as of 7/15, which no doubt has changed in the past two weeks, was 30 percent. OS 185million, float 164million. Institutional participation still over 40%.
Still waking up. Walk him around. Walk him around. The kid's no trooper, send him home. (senior moment)
$FUBO $FUBO Huge SQUEEZE coming!!!
Looks like EMBK is massive dilution risk, OS is like 300M??
$EMBK just remember earnings on the 11th
Grabbing a big position tomorrow, which one you like best?
$DAVE $Embk my two under $1 stocks
Don't see how it can go much lower. How much higher is anyone's guess.
Markforged Holding Corp NYSE: MKFG
MKFG
GoSymbol lookup
Industrials : Machinery | Company profile
Markforged Holding Corporation is a provider of industrial additive manufacturing platform. The Company produces and sells industrial three-dimensional (3D) printers, software, and metal and composite materials. Its platform, The Digital Forge, is an industrial additive manufacturing platform that combines 3D printers and both metal and composite materials with its cloud-based software. Its portfolio of 3D printers includes desktop printers, industrial printers, and metal printers. It provides industrial 3D printing solution for fabricating composite, continuous fiber and metal parts. Its industrial materials enable engineers to develop functional parts across manufacturing environments and applications, including metal and composite. The Company offers four fibers: carbon fiber, fiberglass, kevlar, and high-strength high-temp (HSHT) fiberglass. It provides solutions across aerospace, military and defense, industrial automation, healthcare and automotive industries.
I can't make sense of GEVO. Let's start with a chart first.
OS 201million, float 195million
Institutions own 47percent
Short interest of 27percent
From the latest 8K dated June 15
Item 7.01. Regulation FD Disclosure.
As previously disclosed, on June 5, 2022, Gevo, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors providing for the issuance and sale by the Company of 33,333,336 shares of the Company’s common stock at a price of $4.50 per share, accompanied by Series 2022-A warrants to purchase 33,333,336 shares of the Company’s common stock (each, a “Series 2022-A Warrant”) in a registered direct offering (the “Offering”). The Offering closed on June 8, 2022, and the Company received net proceeds from the Offering of approximately $139.2 million after placement agent’s fees, advisory fees and estimated offering expenses. Following the closing of the Offering, as of June 15, 2022, the Company has cash, cash equivalents, restricted cash and marketable securities of approximately $555.7 million in the aggregate, which includes the net proceeds from the Offering as set forth above.
Over one-half billion American dollars. The company's business model entails making alcohols in a way it believes can be sustainable, meaning net-zero carbon. The company says its primary market will be SAF, or sustainable aviation fuel to airlines, plus another division intended to capture methane from cow manure.
But my takeaway from the latest 10Q is revenues are so close to zilch they might as well be zilch. The company doesn't seem to have the capacity to make any deals that can generate revenue.
The chart tells you that after the high point there have been periods of bounces on the way down. Just don't see much future unless the company announces a major deal.
You are not wrong. I see massive offerings and IF management is good then that money could be well spent. It always comes down to management, bad ones Will just burn away any money tossed at them. Stock also very often separated from company. The stock can be good even if the company is dogshit, we have seen plenty of examples of this. Chuckle.
Can you provide us with a list of your most promising stocks for the weeks ahead? 100%+ potentials would be interesting.
I view it this way: all six of those lowest ranked solar companies that ran up so crazy much were actually dog poop at the time. Back in 2020 and 2021 green energy was a meme. They were viewed for a short time as filet mignon instead of flank steak, which is really what they were all along. More of the general population began thinking the climate scientists might actually be right. It certainly carried over into the stock market.
You are spending alot of time researching this company, do you really believe it Will go Much higher? Curious mind. I can see the sector being strong, but it is, like you Said, a dogshit company
So, Pineapple Energy (PEGY) produces solar power for customers in Hawaii. Of course it has a major competitor in that sunny paradise where balmy breezes blow. In order for it to grow revenues it will have to take market share from that competitor. Here it is:
More to come.
Meanwhile, as for Pineapple Energy (PEGY) and its future share price: If one bothered to examine the three-year charts for those six solar stocks I posted, all six have one clearly defined message. You have one chance and one chance only to make a ton of bank from a rapid run up in price. After that, major and long term dumpage. The others from that Barchart solar sector are played by professional money. They run them up for a few months, take profits, buy them back after they decline, rinse and repeat over the course of several years and longer in some cases since they've been public companies.
Thanks, monk for all the informative and interesting info!
The Forbes article, which, given it was produced by a responsible financial media outlet, was no doubt thoroughly fact checked. No media outlet wants to lose a lawsuit due to putting out false information. It devoted some paragraphs to NextEra (NEE), the third largest electric utility in the country. Here is the five-year weekly chart, courtesy of Maurice.
Although NextEra produces over 50 percent of its power via what can be described as derived from renewables, there are a lot of negatives about the way this company, ranked 187 out of the 500 largest US corporations, operates, too much, in fact, to be discussed at this time.
Did you actually read that Forbe's article? You don't want me to actually provide an adult discussion about it, do you, because, believe me, I can.
Doubt you even examined the May 23 10Q for Pineapple Energy. I did.
My takeaway is the company bought a power supplier in Hawaii and generated $5millio revenue from the sale of a property it owned in Minnetonka, Minnesota.
Currently, the company has two operating divisions. The first one entails a growth through acquisition strategy of buying already operating private companies. How the company is going to achieve this will depend on what the CEO has to say about it. My guess is the company will simply issue stock for the purchase instead of cash.
The next division, and the way it is described to me reads like a bunch of gobbledy gook. Translated, the division is involved in consulting. There are already who knows how many hundreds of private companies operating in the "let us help you, for a big fat fee, to set up your own solar powered house, the building where you do business , etc."
Pineapple Energy doesn't make solar panels. It doesn't make any storage devices. It doesn't make a bottom-line profit for shareholders.
But...why allow facts to get in the way of a damn good story.
$313B,,,,,,,Loading,,,$PEGY,,,,,,GOOOOO,CLEAN ENERGY BILL PASSES……GET IN EARLY
https://www.forbes.com/sites/robertbryce/2022/08/05/big-wind-and-big-solar-will-collect-113-billion-in-tax-credits-this-decade-manchin-schumer-assures--billions-more/?sh=26edb35e29d0
Since Tesla declared a 3 for 1 my share ownership will increase to 3,000 shares.
I would be the last to dismiss the possibility of an outsized mania rally for Pineapple Energy (PGY). First off, my rationale it is simply the next New New Thing in the sector of public traded solar energy companies.
The Republicans will fight the legislation tooth and nail in hopes of delaying its passage for as long as possible. Since Democrats control both houses of the Congress passage is inevitable.
The news that Manchin and Sinema decided to back the bill in the Senate created an eruption in the pricings of solar energy stocks.
So let's have a look. Barchart provides a list of stocks from the sector along with a comprehensive weighted alpha average which can be viewed at the top of the webpage.
https://www.barchart.com/stocks/quotes/CSIQ/competitors?quoteSectors=-SOLA&viewName=main&orderBy=weightedAlpha&orderDir=desc
I have a position in one of the top ranked stocks, ARRY, which has returned me 50 percent since purchase.
Now let's paste in charts of the bottom six tickers from the sector, if for other reason than the traders figure they have the best chances of running 200 to 500 percent in a single trading session. It should be pointed out the bottom five are money losing operations compared those higher up in the rankings, all of which have a nasty habit of actually making bottom line profits from operations.
(all charts are for three-year weekly pricings and volume)
ISUN
HLGN
FTCI
SPI
SUNW
VVPR
I have been updating myself on the latest monkeypox news. As of Aug 5, 7,100 reported cases, 98 percent are gay and/or bisexual men, mostly in New York, San Francisco and Miami, all of which have large gay populations.
Next, the FDA is getting behind a vaccine called Jynneos, still in the trial phase, which, if approved, would increase the available supply, which is woefully small. The current available vaccine for smallpox and which is also effective for monkeypox won't reach 3.6 million doses until May 2023.
Full story available from this link:
https://www.msn.com/en-us/health/medical/the-monkeypox-vaccination-technique-that-could-save-doses/ar-AA10n6YB?ocid=msedgntp&cvid=570b74c9826444d5bd21ef7baf511ed9
FYI: the developer of the Zynneos vaccine is Bavarian Nordic A/S. It trades as a foreign ADR on Cromwell Coulson's stock market, ticker symbol BVNRY (about any foreign OTC ticker symbol ends with a Y)
Since March, the stock has risen from $5(US) to a recent high of $17
What the FDA likes about this vaccine is it can injected similar to the way a tuberculosis vaccine is injected. A single vial can contain up to five doses thus making it easier to vaccinate more people.
Followers
|
2542
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
658141
|
Created
|
06/03/08
|
Type
|
Free
|
Moderator AugustaFriends | |||
Assistants jobynimble JDUB Mark |
Sign up for Email Updates: http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=12753
Chart Lessons by IAMGEND - A must learn for all traders
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76625096
Chart tools:
(1) I use http://www.stockcharts.com for charting
(2) For more info on chart formations, see http://www.chartpatterns.com
(3) Chart indicator definitions http://stockcharts.com/education/IndicatorAnalysis/
(4) Explore Level II here-http://www.hotstockmarket.com/forums/showthread.php?t=14938
(5) For a COMPLETE list of indicator meanings http://www.investopedia.com/categories/technicalanalysis.asp
(6) Top insider trades website: http://www.secform4.com/top-lists.htm
BOARD FOR IHUBS HOTTEST CHART PLAYS
http://investorshub.advfn.com/boards/board.aspx?board_id=18372
WHO'S HOT: http://investorshub.advfn.com/boards/hot_people.asp
CHART YOUR STOCKS HERE: http://stockcharts.com/index.html http://www.profitspi.com/
INSTANT TECHNICAL ANALYSIS: http://www.barchart.com/
NEWS FILTER: http://www.marketwatch.com/
GOOD READ: http://www.bloggingstocks.com/
ALL ABOUT TRADERS: http://www.tradersmagazine.com/
TRACK WHAT THE FUNDS ARE DOING - MY FAVORITE SITE!: http://www.mffais.com
COMMENTARY ON EVERYTHING STOCKS: http://www.istockanalyst.com/
BEST ONLINE BROKERAGE:http://www.nobletrading.com/index.php (ask for Efrain)
MARKET MAKERS: http://www.otcbb.com/dynamic/tradingdata/download/mmids.txt
SHORT DATA: http://shortsqueeze.com/
SEC FILINGS: http://www.sec.gov/edgar/searchedgar/companysearch.html
WALL STREET TABLOID: http://dealbreaker.com/
Posts Today
|
0
|
Posts (Total)
|
658141
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |